A Study on Safety and Efficacy of Sodium-glucose Cotransporter-2 Inhibitors as Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 12, n. 03, 2018. DOI: 10.22377/ajp.v12i03.2625. Disponível em: http://www.asiapharmaceutics.info/index.php/ajp/article/view/2625. Acesso em: 14 apr. 2026.